Rewiring an Addicted Brain | Deborah Mash
The Lindsey Elmore Show
Lindsey Elmore
5.0 • 529 Ratings
🗓️ 17 January 2023
⏱️ 58 minutes
🧾️ Download transcript
Summary
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | More people in the United States each year die from prescription opioid abuse than from heroin and cocaine combined. |
| 0:08.1 | Methadone and buprenorphine are opioid substitution therapies that currently dominate the addiction treatment market. |
| 0:15.0 | But these medications don't actually treat the addiction. |
| 0:18.6 | They still are opiates and they are used to help |
| 0:22.8 | interrupt the pattern of addictive behavior that goes along with searching out prescription opioids. |
| 0:32.1 | Patients need to have access to safe and effective treatment that actually breaks the cycle of something that can feel |
| 0:39.7 | intractable the abuse the dependence the seeking and all of the ongoing withdrawal |
| 0:47.4 | today I am going to be talking with dr. Deborah mash about how psychedelic medicines can help to break the cycle of addiction. |
| 0:57.3 | We also talk about how we can use psychedelic therapies for the treatment of addictions and how we can |
| 1:04.3 | do it using clinically backed research as well as safe and best practices to ensure that the use of the psychedelic is both safe |
| 1:14.8 | and efficacious. This is the Lindsay Elmore Show. Welcome to the Lindsay Elmore Show, a podcast |
| 1:23.7 | for people who deserve to be healthy with honest, open, and enlightening conversations with doctors, thought leaders, |
| 1:31.7 | creatives, and spiritual gurus, you'll walk away with simple and tangible tips and tricks |
| 1:38.5 | that allow you to live your healthiest life so you can pursue your dreams, |
| 1:46.6 | overcome obstacles, and leave your mark. |
| 1:56.3 | Deborah Mash is a neuroscientist inventor and one of the world's foremost experts on the hallucinogenic drug Ibogaine. She is the CEO and founder of DemiRX, a clinical stage drug development company advancing Ibegain and its active metabolite, Noribagane, for the treatment of opioid use disorder. |
| 2:11.9 | DemirX has partnered with Atai Life Sciences, a global biotech platform with a special focus on psychedelic medicine, |
| 2:21.2 | to develop Ibogaine for those suffering from opiate use disorder. Building on the extensive |
| 2:27.9 | human data available around the world on Ibogaine, Demirx and a tie will submit clinical trial applications for |
| 2:36.7 | phase two study in opioid dependent patients to address the current opioid crisis in America. |
| 2:44.5 | She is a professor emeritus of neurology and molecular and cellular pharmacology at the University of Miami Miller School |
| 2:53.0 | of Medicine. She has held uninterrupted NIH funding from the National Institute on Drug Abuse |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Lindsey Elmore, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Lindsey Elmore and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

